IRF9 and systemic lupus erythematosus: Accordingly, therapeutic modulation of the highly interconnected miR-124-3p and miR-302d, which has been designated as predictor of remission in SLE [25] and may participate in regulation of the IFN-induced gene expression in SLE through targeting the IRF9 [59], respectively, might shed new insights into SLE treatment.